Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment

Neuroscience

Volumn 88, Issue 3, 1999, Pages 823-836

  Song, C ^a,b   Merali, Z ^b   Anisman, H ^a  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cytokine; Interleukin 6; Interleukin 1; Interleukin 2; Norepinephrine; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DIHYDROXYPHENYLACETIC ACID; ENDOTOXIN; HOMOVANILLIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; IMMUNOREACTIVITY; LOCUS CERULEUS; MICRODIALYSIS; MONOAMINE RELEASE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SEROTONIN BRAIN LEVEL;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; DOPAMINE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-6; KINETICS; MALE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SEROTONIN;

EID: 0032890170     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00271-1     Document Type: Article

References (83)

1. Abercrombie E. D., Keefe K. A., DiFrischia D. S. and Zigmond M. J. (1989) Differential effects of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52, 1655-1658.
2. 3H]dopamine in rat cultured mesencephalic cells. J. Neurochem. 61, 1284-1290.
3. Anisman H., Borowski T., Kokkinidis L. and Merali Z. (1997) Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responsing for rewarding lateral hypothalamic stimulation. Brain Res. (in press).
4. Anisman H., Kokkinidis L. and Merali Z. (1996) Interleukin-2 decreases accubal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Res. 731, 1-11.
5. Anisman H., Zalcman S., Shanks N. and Zacharko R. M. (1991) Multisystem regulation of performance deficits induced by stressors: an animal model of depression. In Neuromethods, Vol. 19: Animal Models of Psychiatry (eds Boulton A., Baker G. and Martin-Iverson M.), Vol. 2, pp. 1-59. Humana, New Jersey.
6. Anisman H., Zalcman S. and Zacharko R. M. (1993) The impact of stressors on immune and central neurotransmitter activity: bidirectional communication. Rev. Neurosci. 4, 147-180.
7. Araujo B. M., Lapchak P. A., Collier B. and Quirion R. (1989) Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res. 498, 257-266.
8. Banks W. A., Kastin A. J. and Durham D. A. (1989) Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res. Bull. 23, 433-437.
9. Bartholomew S. A. and Hoffman S. A. (1993) Effects of peripheral cytokine injections on multiple unit activity in the anterior hypothalamic area of the mouse. Brain Behav. Immun. 7, 301-316.
10. Benveniste H. (1987) Brain microdialysis. J. Neurochem. 49, 729-734.
11. Blalock J. E. (1994) The syntax of immune-endocrine communication. Immunol. Today 15, 504-544.
12. Brady L. S., Lynn A. B., Herkenham M. and Gottesfeld Z. (1994) Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J. Neurosci. 14, 4951-4964.
13. Dantzer R., Bluther R.-M., Aubert A., Goodall G., Bret-Dibat J.-L., Kent S., Goujon E., Laye S., Parnet P. and Kelley K. W. (1996) Cytokine actions on behavior. In Cytokines and the Nervous System (ed. Rothwell N. J.), pp. 117-144. R.G. Landes, London.
14. De Sarro G. B., Masuda Y., Ascioti C., Audino M. G. and Nistico G. (1990) Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin-2 in rats are antagonized by naloxone. Neuropharmacology 29, 167-179.
15. De Simoni M. G., Del Bo R., De Luigi A., Simard S. and Forloni G. (1995) Central endotoxin induces different patterns of interleukin (IL)-1β and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology 136, 897-902.
16. Deakin J. F. W., Graeff F. G. and Guimaraes F. S. (1993) Microdialysis studies with 5-HT reuptake inhibitors. Reply. Trends pharmac. Sci. 14, 398.
17. Deutch A. Y. and Roth R. H. (1990) The determinants of stress-induced activation of the prefrontal cortical dopamine system. In Progress in Brain Research (eds Uylings H. B. M., Van Eden C. G., De Bruin J. P. C., Corner M. A. and Feenstra M. G. P.), Vol. 85, pp. 367-403. Elsevier, New York.
18. Dunn A. J. (1990) Interleukin-1 as a stimulator of hormone secretion. Prog. Neuroendocrinimmunol. 3, 26-34.
19. Dunn A. J. (1995). Interactions between the nervous system and the immune system. In Psychopharmacology: The Fourth Generation of Progress (eds Bloom F. E. and Kupfer D. L.), pp. 719-731. Raven, New York.
20. Ericcson A., Kovacs K. J. and Sawchenko P. E. (1994) A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14, 897-913.
21. Ershler W. B. (1993) Interleukin-6: a cytokine for gerontologist. J. Am. geriatr. Soc. 41, 176-181.
22. Farrar W. L., Kilian P. L., Ruff M., Hill J. M. and Pert C. B. (1987) Visualization and characterization of interleukin-1 receptors in brain. J. Immunol. 139, 459-463.
23. Fibiger H. C. and Phillips A. G. (1988) Mesocorticolimbic dopamine systems and reward. In The Mesocorticolimbic Dopamine System (eds Kalivas P. W. and Nemeroff C. B.), pp 206-215. N.Y. Acad. Sci., New York.
24. Fibiger H. C., LePiane F. G., Jakubovic A. and Phillips A. G. (1987) The role of dopamine in intracranial self-stimulation of the ventral tegmental area. J. Neurosci. 7, 3888-3896.
25. Frei K., Malipiero U. V., Leist R. M., Zinkernagel R. M., Schwab M. E. and Fontana A. (1989) On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19, 689-694.
26. Gradient R. A. and Otten U. (1993) Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci. Lett. 153, 13-16.
27. Herman J. P. and Cullinan W. E. (1997) Neurocircuitry of stress: central control of hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20, 78-84.
28. Hopkins S. J. and Rothwell N. J. (1995) Cytokines and the nervous system. 1. Expression and recognition. Trends Neurosci. 18, 83-88.
29. Imura H., Fukata J.-I. and Mori T. (1991) Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin. Endocr. 35, 107-115.
30. Kabiersch A., Del Rey A., Honegger C. G. and Besedovsky H. O. (1988) Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immun. 2, 267-274.
31. Karanth S. and McCann S. M. (1991) Anterior pituitary hormone control by interleukin 2. Proc. natn. Acad. Sci. U.S.A. 88, 2961-2965.
32. Katsuura G., Gottschall P. E. and Arimura A. (1988) Identification of a high-affinity receptor for interleukin-1 beta in rat brain. Biochem. biophys. Res. Commun. 156, 61-67.
33. Kent S., Bluthe R.-M., Kelley K. W. and Dantzer R. (1992) Sickness behavior as a new target for drug development. Trends pharmac. Sci. 13, 24-28.
34. Kokkinidis L. and McCarter L. (1990) Postcocaine depression and sensitization of brain stimulation reward: analysis of reinforcement and performance effects. Pharmac. Biochem. Behav. 36, 463-471.
35. Lacosta S., Merali Z. and Anisman H. (1995) Cytokine-induced endocrine, neurochemical and behavioral alterations. Soc. Neurosci. Abstr. 21, 1397.
36. Lacosta S., Merali Z., Zalcman S. and Anisman H. (1994) Time-dependent in vivo mesolimibic dopamine variations following antigenic challenge. Brain Res. 664, 225-230.
37. Lapchak P. A. (1992) A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuro Report 3, 165-168.
38. Lapchak P. A., Araujo D. M., Quirion R. and Beaudet A. (1991) Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin-2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience 44, 173-184.
39. Li A.-J., Katafuchi T., Oda S., Hori T. and Oomura Y. (1997) Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 748, 30-38.
40. Linthorst A. C. E., Flachskamm C., Muller-Preuss P., Holsboer F. and Reul J. M. H. M. (1995) Effect of bacterial endotoxin and interleukin-1β on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J. Neurosci. 15, 2920-2934.
41. Lyson K. and McCann S. M. (1991) The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 54, 262-266.
42. Lyson K. and McCann S. M. (1993) Alpha-melanocyte-stimulating hormone abolishes IL-1 and IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology 58, 191-195.
43. Maes M. (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmac. 19, 11-38.
44. Maier S. F. and Watkins L. R. (1995) Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 695, 279-282.
45. Maness L. M., Banks W. A., Zadina J. E. and Kastin A. J. (1995) Selective transport of blood-borne interleukin-1 alpha into the posterior division of the septum of the mouse brain. Brain Res. 70, 83-88.
46. Masana M. I., Heyes M. P. and Mefford I. N. (1990) Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge. Prog. Neuropsychopharmac. 14, 609-621.
47. McClain C., Cohen D., Phillips R., Ott L. and Young B. (1991) Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J. Lab. clin. Med. 118, 225-231.
48. Merali Z., Lacosta S. and Anisman H. (1997) Effects of interleukin-1β and mild stress on alterations of norephinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res. 761, 225-235.
49. Merrill J. E. (1990) Interleukin-2 effects in the central nervous system. Ann. N. Y. Acad. Sci. 594, 188-199.
50. Mohankumar P. S., Thyagarajan S. and Quadri S. K. (1991) Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from hypothalamus in vivo. Life Sci. 48, 925-930.
51. Mohankumar P. S., Thyagarajan S. and Quadri S. K. (1993) Interleukin-1β increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo. Brain Res. Bull. 31, 745-748.
52. Muramami N., Fukata J., Tsukada T., Kobayashi H., Ebisui O., Segawa H., Muro S., Imura H. and Nakao K. (1993) Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology 133, 2574-2578.
53. Naitoh Y., Fukata J., Tominaga T., Nakai Y., Tamai S., Mori K. and Imura H. (1988) Interleukin-6 stimulates the secretion of adrenocorticotrophic hormone in conscious, freely moving rats. Biochem. biophys. Res. Commun. 155, 1459-1461.
54. Nistico G. (1993) Communications among central nervous system, endocrine and immune systems: interleukin-2. Prog. Neurobiol. 40, 463-475.
55. Nistico G. and De Sarro G. (1991) Is interleukin-2 a neuromodulator in the brain? Trends Neurosci. 14, 146-150.
56. Paulson P. E. and Robinson T. E. (1995) Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19, 56-65.
57. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
58. Petitto J. M., McCarthy D. B., Rinker C. M., Huang Z. and Getty T. (1997) Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J. Neuroimmunol. 73, 183-190.
59. Plata-Salaman C. R. (1991) Immunoregulators in the nervous system. Neurosci. biobehav. Rev. 15, 185-215.
60. Puglisi-Allegra S., Imperato A., Angelucci L. and Cabib S. (1991) Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Res. 554, 217-222.
61. Quan N., Sundar S. K. and Weiss J. M. (1994) Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol. 49, 125-134.
62. Ringheim G. E., Burgher K. L. and Heroux J. A. (1995) Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of IL-6 production in the brain. J. Neuroimmunol. 63, 113-123.
63. Rivest S. (1995) Molecular mechanisms and neural pathways mediating the influence of interleukin-1 on the activity of neuroendocrine CRF motoneurons in the rat. Int. J. dev. Neurosci. 13, 135-146.
64. Rivier C. (1990) Role of endotoxin and interleukin-1 in modulating ACTH, LH and sex steroid secretion. In Circulating Regulatory Factors and Neuroendocrine Function (eds Porter J. C. and Jezova D.), pp. 295-302. Plenum, New York.
65. Rivier C. (1993) Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat. Ann. N. Y. Acad. Sci. 697, 97-105.
66. Rothwell N. J. and Hopkins S. J. (1995) Cytokines and the nervous sytem. II: Actions and mechanisms of action. Trends Neurosci. 18, 130-136.
67. Schobitz B., De Kloet E. R. and Holsboer F. (1994) Gene expression and function of interleukin-1, interleukin-6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44, 397-432.
68. Seto D., Kar S. and Quirion R. (1997) Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices. Br. J. Pharmac. 120, 1151-1157.
69. Shintani F., Kanba S., Nakaki T., Nibuya M., Kinoshita N., Suzuki E., Yagi G., Kato R. and Asai M. (1993) Interleukin-1β augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus. J. Neurosci. 13, 3574-3581.
70. Shintani F., Nakaki T., Kanba S., Sato K., Yagi G., Shiozawa M., Aiso S., Kato R. and Asai M. (1995) Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J. Neurosci. 15, 1961-1970.
71. Smagin G. N., Swiergiel A. H. and Dunn A. J. (1996) Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone. Psychoneuroendocrinology 21, 83-93.
72. Terao A., Oikawa M. and Saito M. (1994) Tissue-specific increase in norepinephrine turnover by central interleukin-1, but not by interleukin-6, in rats. Am. J. Phsyiol 266, R400-R404.
73. Vandenabeele P. and Fiers W. (1991) Is amyloidogenesis during Alzheimer's disease due to an IL-1/I1-6-mediated "acute phase response" in the brain? Immunol. Today 12, 217-219.
74. Wasselningh S. L., Levine B., Fox R. J., Choi S. and Griffin D. E. (1994) Intracerebral cytokine mRNA expresion during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2T cell response. J. Immunol. 152, 1289-1297.
75. Watkins L. R., Maier S. F. and Goehler L. E. (1995) Cytokine-to brain-communication: a review and analysis of alternative mechanisms. Life Sci. 11, 1011-1026.
76. Westerink B. H. C. (1995) Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 70, 103-124.
77. Wise R. A. (1985) The anhedonia hypothesis: mark III. Behav. Brain Sci. 8, 178-186.
78. Wise R. A., Bauco P., Carlezon W. A. and Trojniar W. (1994) Self-stimulation and drug reward mechanisms. Ann. N. Y. Acad. Sci. 654, 192-198.
79. Wong P., Teo W. L. and Lee T. (1993) A microdialysis study on stratal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine. NeuroReport 5, 53-56.
80. Zacharko R. M., Bowers W. J., Kokkinidis L. and Anisman H. (1983) Region specific reductions of intracranial self-stimulation after uncontrollable stress: possible effects on reward processes. Behav. Brain Res. 9, 129-141.
81. Zalcman S., Green-Johnson J., Murray L., Nance D. M., Dyck D., Anisman H. and Greenberg A. (1994) Cytokine-specific central monoamine alterations induced by interleukin (IL)-1, IL-2 and IL-6. Brain Res. 643, 40-99.
82. Zetterstrom T., Sharp T., Collin A. K. and Ungerstedt U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmac. 148, 327-334.
83. Zhou D., Shanks N., Riechman R. E., Liang R., Kusnecov A. W. and Rabin B. S. (1996) Interleukin 6 modulates interleukin-1 and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats. Neuroendocrinology 63, 227-236.